Enhanced monitoring of tenofovir-lamivudine-dolutegravir (TLD) replacing first-line HIV-antiretroviral treatment in Chiradzulu District, Malawi (EMEDT)
Principal investigator
-
Location
-
Topic
-
Methodology
-
ReferenceEPI024-05
-
Views154
-
Downloaded0
Purpose of study
Purpose of study
Study status
Study timeline
Documents
-
1445-abstract-2024-09-23.pdf 188 KB
Publications
No publications recorded
Previous study
Next study